News
10h
Pharmaceutical Technology on MSNRoche extends SMA market lead with Evrysdi tablet approval in EuropeAlready offering the only non-invasive treatment for SMA in liquid form, Roche’s Evrysdi now comes as a tablet.
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with ...
Early intervention in Spinal Muscular Atrophy is crucial for better outcomes, emphasizing the need for timely treatment to ...
Dr. Tejal Aslesh Tailor is an accomplished neuroscientist and molecular biologist with years of expertise in preclinical ...
MRI imaging scans can track muscle changes in SMA children given Spinraza, a study found, with better results seen with early ...
The European Commission (EC) has approved a label extension for Roche’s Evrysdi (risdiplam) to include a tablet for people living with SMA.
Spinraza (nusinersen) treatment helped school-age children with SMA be more independent in tasks involving their arms and ...
Rainbow Children's Hospital in Secunderabad has successfully administered gene therapy to its eighth patient with Spinal Muscular Atrophy (SMA). The therapy, using Zolgensma, offers hope to families ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results